Clinical Trial Update: Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) using two administration routes; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• MeMuRu-OKA

Snippet

Sponsor: GlaxoSmithKline | Conditions: Measles, Mumps | Phase 3 | Status: COMPLETED